Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

ESAF and BAF launch fund of UCITS III alpha funds

Thursday, April 08, 2010
Opalesque Industry Update - ESAF in Luxembourg announces the launch of a new Fund of UCITS III Funds.

ESAF (Espírito Santo Gestão de Patrimónios, S.A), the investment manager, designated BAF (Blue Activos Financeiros – SGP, S.A), an independent asset management company specialized in alternative investment strategies based in Portugal, as the investment advisor of the Fund.

This new Luxemburg Fund, Dynamic Alpha Portfolio UCITS III is one of the first to be launched in Europe in this new generation of strongly regulated “Flexible Investment Funds”. As the name suggests this Fund is an “Active Managed Portfolio” of UCITS III “Alpha” Funds.

Dynamic Alpha Portfolio UCITS III Fund is regulated by EU UCITS III directive, transparent, liquid and therefore eligible for investment from Pension Funds and Insurance Companies in Europe but also aiming to serve the growing global demand, particularly in Asia and Latin America.

Dynamic Alpha Portfolio UCITS III Fund main features:

• The Fund objective is to provide its investors with capital growth, mainly by investing in units of UCITS III offering different strategies. The Investment philosophy is to deliver a positive performance regardless of market conditions.
• Target Return - Euribor 3M + 4% - 8%
• Targeting low volatility and low beta levels.
• Target Volatility < 6%
• Alpha is driven by identifying, and finding the best way to capitalise on, specific manager skill.
• Investing in a selection of UCITS III funds within the most liquid assets / strategies (Long/Short Equity, Global Macro, CTA, Currency, Volatility).
• # Managers: 12-15 managers
• Maximum position size: 12%


ESAF – Espírito Santo International Management, SA (Lux) is part of Grupo Banco Espírito Santo. www.esfg.com

About BAF
• Founded in 2004 as an independent firm, to manage the assets of high net worth individuals, family offices and institutional clients.
• 10 years experience in absolute return strategies and 16 years in capital markets.
• Strength in depth – Experienced team who is 100% focused on asset allocation strategies, portfolio construction and risk management. www.blue-investments.com

pgoncalves@esaf.pt / damaral@blue-investments.com


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its